Sector revisions Charles River Laboratories International, Inc.

Stocks

Real-time Estimate Cboe BZX Other stock markets 12:00:11 2026-06-17 pm EDT			5-day change	1st Jan Change
189.14 ^USD	+2.35%		+1.37%	-5.33%

08:07am	Morgan Stanley Upgrades Charles River Laboratories International to Overweight From Equal Weight, Adjusts PT to $220 From $185	MT
Jun. 05	Charles River Laboratories Has Potential to Outperform in 2H 2026, RBC Says	MT

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	4m. EPS revision	1y. EPS revision	Nbr of analysts
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.			15
LONZA GROUP AG			23
REVOLUTION MEDICINES, INC.			21
BEONE MEDICINES AG			27
IQVIA HOLDINGS INC.			19
CELLTRION, INC.			24
ASCENDIS PHARMA A/S	-	-	18
MEDPACE HOLDINGS, INC.			12
EUROFINS SCIENTIFIC SE			14
IONIS PHARMACEUTICALS, INC.			23
ICON PUBLIC LIMITED COMPANY			16
TEMPUS AI, INC.			15
BIO-TECHNE CORPORATION			13
ABIVAX			6
QIAGEN N.V.			14
ALKERMES PLC			16
PRAXIS PRECISION MEDICINES, INC.			17
PROTAGONIST THERAPEUTICS, INC.			13
KYMERA THERAPEUTICS, INC.			21
Average			17
Weighted average by Cap.			19